COMMUNIQUÉS West-GlobeNewswire
-
MEDVi QUAD Formula Update Confirmed for 2026: Apomorphine Replaces PT-141 in Current 4-in-1 Combination
17/09/2026 -
Desert Hope Treatment Center Names Blaise Schafer Lead Clinician for New First Responders Program
17/09/2026 -
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
16/09/2026 -
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
16/09/2026 -
COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING
17/09/2026 -
AdCare Hospital Promotes Lilly Cabral to Role of Clinical Director
17/09/2026 -
Jack Ady Cancer Centre launches Alberta's first researcher-led cancer clinical trial outside major urban centres
16/09/2026 -
Tiderock Companies, Inc. to Become Aloros Corporation, Sharpening Strategic Focus on Advanced Manufacturing
16/09/2026 -
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
16/09/2026 -
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
16/09/2026 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/09/2026 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
16/09/2026 -
Earth Science Tech, Inc. Uplists to OTCQB Venture Market
16/09/2026 -
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
16/09/2026 -
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
16/09/2026 -
Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California
16/09/2026 -
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
16/09/2026 -
Roto-Rooter Buys Largest Franchisee Territory
16/09/2026 -
Flow Neuroscience launches FL-100 in the US, the first FDA-approved at-home tDCS treatment for depression
16/09/2026
Pages